1200P A Phase II Single-Arm Interventional Trial Evaluating the Activity and Safety of CABOzantinib (CBZ) Plus TEMozolomide (TMZ) in Lung and Gastroenteropancreatic Neuroendocrine Neoplasms (Gep-Nens) Progressed after SSA Therapy, Everolimus, Sunitinib or PRRT: CABOTEM Trial